Can a simple blood test predict who will get chronic ITP?

NCT ID NCT04070599

Completed Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at blood samples from 70 children and adults newly diagnosed with immune thrombocytopenic purpura (ITP), a condition that causes easy bruising and bleeding. Researchers wanted to see if certain immune and blood markers could predict whether the disease would become chronic (lasting more than 12 months). The goal is to better understand differences between children and adults and improve early treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors predict early which ITP patients will develop chronic disease, allowing for more personalized monitoring and treatment.
What could go wrong: This is an observational analysis of existing samples, not a treatment trial. The findings may not lead to immediate changes in care and need further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOIMMUNE THROMBOCYTOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune thrombocytopenia autoimmune thrombocytopenic purpura Purpura, Thrombocytopenic, Idiopathic thrombocytopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTOIMMUNE THROMBOCYTOPENIA IMMUNE THROMBOCYTOPENIC PURPURA THROMBOPENIA

Contacts and locations

Locations

CHU de Bordeaux

Bordeaux, 33000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.